Vtv Therapeutics Inc. (VTVT) SEC Filings — 2025
16 SEC filings for Vtv Therapeutics Inc. (VTVT) in 2025.
Filings
- Vtv Therapeutics Inc. 8-K Filing — 8-K · Dec 19, 2025
- vTv Therapeutics' Q3 Loss Widens Amid R&D Surge, Cash Reserves Boosted — 10-Q · Nov 6, 2025
- vTv Therapeutics Files 8-K for Regulation FD Disclosure — 8-K · Sep 10, 2025
- vTv Therapeutics Files 8-K for Material Agreement — 8-K · Sep 2, 2025
- vTv Therapeutics Narrows Q2 Loss Amid R&D Cuts — 10-Q · Aug 12, 2025
- vTv Therapeutics Schedules Shareholder Vote — 8-K · Jun 12, 2025
- vTv Therapeutics Files 8-K: Director/Officer Changes & Financials — 8-K · May 19, 2025
- vTv Therapeutics Files 8-K for Routine Disclosures — 8-K · May 16, 2025
- vTv Therapeutics Files Q1 2025 10-Q — 10-Q · May 15, 2025
- vTv Therapeutics Files 2024 Proxy Statement — DEF 14A · Apr 25, 2025
- vTv Therapeutics Announces Leadership and Compensation Changes — 8-K · Apr 11, 2025
- vTv Therapeutics Files 8-K for March 31, 2025 — 8-K · Mar 31, 2025
- Vtv Therapeutics Inc. 10-K Filing — 10-K · Mar 20, 2025
- vTv Therapeutics Files 8-K — 8-K · Mar 17, 2025
- vTv Therapeutics Reports Board and Officer Changes — 8-K · Feb 27, 2025
- vTv Therapeutics Files 8-K Report — 8-K · Jan 13, 2025